Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)

NCT00051129 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

291

Enrollment

INDUSTRY

Sponsor class

Conditions

Macular Degeneration
Maculopathy, Age-Related
Age-Related Maculopathies
Age-Related Maculopathy
Maculopathies, Age-Related

Interventions

DRUG: Anecortave Acetate 15 mg sterile suspension
OTHER: Anecortave Acetate Vehicle

Sponsor

Alcon Research